Instil Bio (TIL) Competitors $22.57 +1.98 (+9.62%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$22.51 -0.06 (-0.27%) As of 05:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends TIL vs. BCAX, CRGX, DNTH, KURA, PHAR, TECX, IMNM, AUTL, CGEM, and HUMAShould you be buying Instil Bio stock or one of its competitors? The main competitors of Instil Bio include Bicara Therapeutics (BCAX), CARGO Therapeutics (CRGX), Dianthus Therapeutics (DNTH), Kura Oncology (KURA), Pharming Group (PHAR), Tectonic Therapeutic (TECX), Immunome (IMNM), Autolus Therapeutics (AUTL), Cullinan Therapeutics (CGEM), and Humacyte (HUMA). These companies are all part of the "pharmaceutical products" industry. Instil Bio vs. Bicara Therapeutics CARGO Therapeutics Dianthus Therapeutics Kura Oncology Pharming Group Tectonic Therapeutic Immunome Autolus Therapeutics Cullinan Therapeutics Humacyte Bicara Therapeutics (NASDAQ:BCAX) and Instil Bio (NASDAQ:TIL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, community ranking, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Does the MarketBeat Community believe in BCAX or TIL? Instil Bio received 93 more outperform votes than Bicara Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Bicara Therapeutics an outperform vote while only 50.75% of users gave Instil Bio an outperform vote. CompanyUnderperformOutperformBicara TherapeuticsOutperform Votes8100.00% Underperform VotesNo VotesInstil BioOutperform Votes10150.75% Underperform Votes9849.25% Does the media prefer BCAX or TIL? In the previous week, Bicara Therapeutics had 3 more articles in the media than Instil Bio. MarketBeat recorded 3 mentions for Bicara Therapeutics and 0 mentions for Instil Bio. Bicara Therapeutics' average media sentiment score of 0.10 beat Instil Bio's score of -1.00 indicating that Bicara Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Bicara Therapeutics Neutral Instil Bio Negative Is BCAX or TIL more profitable? Bicara Therapeutics' return on equity of 0.00% beat Instil Bio's return on equity.Company Net Margins Return on Equity Return on Assets Bicara TherapeuticsN/A N/A N/A Instil Bio N/A -37.44%-25.08% Do institutionals and insiders hold more shares of BCAX or TIL? 60.6% of Instil Bio shares are held by institutional investors. 46.5% of Instil Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better earnings and valuation, BCAX or TIL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBicara TherapeuticsN/AN/AN/AN/AN/AInstil BioN/AN/A-$156.09M-$11.56-1.95 Do analysts prefer BCAX or TIL? Bicara Therapeutics currently has a consensus target price of $43.75, suggesting a potential upside of 257.43%. Instil Bio has a consensus target price of $114.00, suggesting a potential upside of 405.10%. Given Instil Bio's higher probable upside, analysts clearly believe Instil Bio is more favorable than Bicara Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bicara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Instil Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryBicara Therapeutics beats Instil Bio on 7 of the 11 factors compared between the two stocks. Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TIL vs. The Competition Export to ExcelMetricInstil BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$147.38M$3.05B$5.66B$9.11BDividend YieldN/A1.81%5.28%4.00%P/E Ratio-1.9546.9088.3918.31Price / SalesN/A288.281,075.2481.15Price / CashN/A188.9637.4433.55Price / Book0.654.095.124.76Net Income-$156.09M-$41.02M$108.98M$223.10M7 Day Performance-14.22%1.96%0.49%0.18%1 Month Performance9.51%-4.73%-0.88%-1.98%1 Year Performance91.76%-0.63%26.71%23.41% Instil Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TILInstil Bio2.753 of 5 stars$22.57+9.6%$114.00+405.1%+92.2%$145.27MN/A0.00410Negative NewsBCAXBicara TherapeuticsN/A$11.65+0.3%$43.75+275.5%N/A$633.99MN/A0.0032Upcoming EarningsGap UpCRGXCARGO Therapeutics3.2134 of 5 stars$13.66+1.5%$31.80+132.8%-84.3%$628.77MN/A-3.21116Analyst RevisionDNTHDianthus Therapeutics2.1927 of 5 stars$21.10-0.5%$46.43+120.0%+10.3%$624.56M$2.83M-8.4480Short Interest ↑News CoverageKURAKura Oncology4.7065 of 5 stars$7.91-0.9%$27.38+246.1%-57.9%$615.08MN/A-3.35130PHARPharming Group2.9376 of 5 stars$9.00-1.1%$27.00+200.0%-34.0%$610.52M$285.75M-34.62280TECXTectonic Therapeutic2.3628 of 5 stars$41.18-11.9%$72.25+75.4%N/A$607.53MN/A-6.99120Gap DownIMNMImmunome1.8811 of 5 stars$9.69-2.6%$28.83+197.6%-32.0%$604.85M$14.02M-1.1940Insider TradeGap UpAUTLAutolus Therapeutics3.1123 of 5 stars$2.26-4.6%$10.40+360.2%-64.0%$601.36M$1.70M-1.87330CGEMCullinan Therapeutics2.7267 of 5 stars$10.30-2.4%$31.67+207.4%-42.5%$599.77MN/A-3.6330Analyst RevisionHUMAHumacyte3.3564 of 5 stars$4.51-2.2%$13.71+204.1%+32.4%$567.62M$1.57M-3.37150Gap Down Related Companies and Tools Related Companies BCAX Competitors CRGX Competitors DNTH Competitors KURA Competitors PHAR Competitors TECX Competitors IMNM Competitors AUTL Competitors CGEM Competitors HUMA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TIL) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
